IMMUNE NETWORK

  • 제7권3호
  • /
  • Pages.124-132
  • /
  • 2007
  • /
  • 1598-2629(pISSN)
  • /
  • 2092-6685(eISSN)
대한면역학회 (The Korean Association of Immunobiologists)
권호 표지

Anti-CD3 Antibody Induces IL-10-producing $CD4^+CD25^+$ Regulatory T Cells, Which Suppress T Cell Response in Rheumatoid Arthritis Patients

  • Yoon, Bo-Young (Department of Internal Medicine, Inje Univeresity Ilsan Paik Hospital) ;
  • Cho, Mi-La (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea) ;
  • Hong, Yeon-Sik (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea) ;
  • Jhun, Joo-Yeon (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea) ;
  • Park, Mi-Kyung (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea) ;
  • Park, Kyung-Su (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea) ;
  • Park, Sung-Hwan (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea) ;
  • Kim, Ho-Youn (Division of Rheumatology, Department of Internal Medicine, The Center for Rheumatic Diseases, and The Rheumatism Research Center (RhRC), Catholic Research Institutes of Medical Sciences, Catholic University of Korea)
  • 발행 : 2007.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Regulatory T cells (Tregs) have been investigated intensively for some decades. These cells regulate the immune system, prevent overactivated immune responses and can be used therapeutically. For rheumatoid arthritis (RA), understanding the functions and status of Tregs is an important step for understanding immune regulation in this autoimmune disease. Methods: We investigated the percentages, phenotypes and suppressive functions of $CD4^+CD25^+$ Tregs in peripheral blood (PB) of patients with RA. Results: The percentages were higher in the patients (n=12) than in healthy controls (n=10), and the cells expressed the $CD45RB^{low}$, CTLA-4 and CCR7 phenotypes. We also investigated the expression of Foxp3 and secretion of interleukin (IL)-10 induced $CD4^+CD25^+$ Tcells by anti-CD3 antibody treatment. A suppressive function of the patients' cells was shown through coculture with $CD4^+CD25^-$ T cells in vitro. Conclusion: We suggest that, despite their increased numbers and suppressive function, they manage the ongoing inflammation ineffectively. It might be possible to apply IL-10 to induce the proliferation of IL-10-producing Tregs as therapy for RA.

키워드

참고문헌

  1. Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 85;307-310, 1996 https://doi.org/10.1016/S0092-8674(00)81109-5
  2. Weyand CM: New insight into the pathogenesis of rheumatoid arthritis. Rheumatology 39;3-8, 2000
  3. Jonuleit H, Schmitt E: The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171 ;6323-6327, 2003 https://doi.org/10.4049/jimmunol.171.12.6323
  4. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity and transplantation tolerance. Immunol Rev 182;18-32, 2001 https://doi.org/10.1034/j.1600-065X.2001.1820102.x
  5. Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2;389-400, 2002 https://doi.org/10.1038/nrc801
  6. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192;303-310, 2000 https://doi.org/10.1084/jem.192.2.303
  7. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S: Stimulation of CD25( +)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3;135-142, 2002 https://doi.org/10.1038/ni759
  8. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299;1057-1061, 2003 https://doi.org/10.1126/science.1079490
  9. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4;330-336, 2003 https://doi.org/10.1038/ni904
  10. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various auto-immune diseases. J Immunol 155;1151-1164, 1995
  11. O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system conrrol. Nat Med 10;801-805, 2004 https://doi.org/10.1038/nm0804-801
  12. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109;131-140, 2002 https://doi.org/10.1172/JCI0213605
  13. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI: Defective suppressor function in CD4+CD25+T-cells from patients with type 1 diabetes. Diabetes 54;92-99, 2005 https://doi.org/10.2337/diabetes.54.1.92
  14. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4(+ )CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype and function between peripheral blood and synovial fluid. Arthritis Rheum 50;2775-2785, 2004 https://doi.org/10.1002/art.20499
  15. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C: Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33; 215-223, 2003 https://doi.org/10.1002/immu.200390024
  16. Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T: Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 43;617-627, 2000 https://doi.org/10.1002/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B
  17. Lawson CA, Brown AK, Bejarano V, Douglas SH, Burgoyne CH, Greenstein AS, Boylston AW, Emery P, Ponchel F, Isaacs JD: Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology 29; Epub ahead of print, 2006
  18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31;315-324, 1988 https://doi.org/10.1002/art.1780310302
  19. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF alpha therapy. J Exp Med 200;277-285, 2004 https://doi.org/10.1084/jem.20040165
  20. Suri-Payer E, Cantor H: Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun 16;311-323, 2001
  21. van Amelsfort JM, van Roon JA, Noordergraaf M, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: Proinflammatory mediated-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56;710-713, 2007 https://doi.org/10.1002/art.22415
  22. Lamas M, Sanz E, Martin-Parras L, Espel E, Sperisen P, Collins M, Silva AG: Glucocorticoid hormones upregulate interleukin 2 receptor alpha gene expression. Cell Immunol 151;437-450, 1993 https://doi.org/10.1006/cimm.1993.1252
  23. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, Snijders A, Offringa R, de Vries RR, Toes RE: CD25 + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 48;1452-1460, 2003 https://doi.org/10.1002/art.11063
  24. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL: Regulatory interactions between CD45RBhigh and CD45RBlow CD4 + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179;589-600, 1994 https://doi.org/10.1084/jem.179.2.589
  25. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167;1245-1253, 2001 https://doi.org/10.4049/jimmunol.167.3.1245
  26. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M: Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104; 895-903, 2004 https://doi.org/10.1182/blood-2004-01-0086
  27. Wraith DC: Role of interleukin-l0 in the induction and function of natural and antigen-induced regulatory T cells. J Autoimmun 20;273-275, 2003 https://doi.org/10.1016/S0896-8411(03)00046-5
  28. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA: Natural and induced CD4+CD25+ cells educate CD4+ CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta and IL-10. J Immunol 172;5213-5221, 2004 https://doi.org/10.4049/jimmunol.172.9.5213
  29. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA: A role for TGF-beta in the generation and expansion of CD4+ CD25+ regulatory T cells from human peripheral blood. J Immunol 166;7282-7289, 2001 https://doi.org/10.4049/jimmunol.166.12.7282
  30. Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS: TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am J Transplant 4;1614-1627, 2004 https://doi.org/10.1111/j.1600-6143.2004.00566.x
  31. Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S: Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 16;1189-1201, 2004 https://doi.org/10.1093/intimm/dxh122
  32. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199;1455-1465, 2004 https://doi.org/10.1084/jem.20040139